查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1988936

2026年全球体外诊断（IVD）品管市场报告

In Vitro Diagnostics (IVD) Quality Control Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，体外诊断（IVD）品管市场显着扩张。预计该市场将从2025年的14.8亿美元成长到2026年的16.1亿美元，复合年增长率（CAGR）为8.5%。过去几年成长要素包括感染疾病负担日益加重、IVD设备的广泛应用、监管机构对诊断准确性的日益重视、临床实验室网络的扩张以及人们对实验室质量标准的日益关注。

体外诊断（IVD）品管市场预计在未来几年将保持强劲成长，到2030年将达到22.4亿美元，复合年增长率（CAGR）为8.6%。预测期内的成长预计将受到以下因素的推动：对分子诊断更高精度的需求不断增长、医疗保健数位化进程的推进、自动化检测系统的扩展、医疗基础设施投资的增加以及监管合规要求的日益严格。预测期内的主要趋势包括：更加重视诊断的准确性和可靠性、日益关注品质合规性和标准化、外部品质评估项目的扩展、多重和分子诊断测试检验的加强以及自动化品质监控系统的广泛应用。

感染疾病的日益流行预计将推动体外诊断（IVD）品管市场的成长。感染疾病是由细菌、病毒、真菌和寄生虫等致病微生物引起的疾病，可透过人与人之间的直接或间接传播。由于抗生素抗药性的增加等因素，感染疾病的盛行率正在上升。这使得常见感染疾病的治疗和控制变得更加困难，从而促进了感染的传播。 IVD品管在确保诊断测试结果的准确性、可靠性和一致性方面发挥着至关重要的作用，有助于早期发现感染疾病病原体，并支持有效的临床决策和患者管理。例如，根据总部位于瑞士的国际公共卫生组织－世界卫生组织（WHO）的数据，截至2024年10月，2023年全球约有820万人新确诊结核病，高于2022年的约750万人，使结核病成为全球最致命的感染疾病。因此，感染疾病的蔓延推动了体外诊断（IVD）品管市场的成长。

体外诊断 (IVD)品管市场的主要企业正致力于整合先进技术，例如嵌入式条码扫描系统，以提高效率、简化诊断工作流程并减少处理错误。嵌入式条码扫描系统是紧凑型固定设备和智慧视觉模组，可自动读取条码并即时撷取资料。这有助于在整个诊断过程中实现准确的检体识别、自动资料输入和更高的可追溯性。例如，2023 年 11 月，总部位于荷兰的数位科技公司 Newland EMEA 在 MEDICA展览会上发表了一系列全新的 IVD 专用条码扫描产品。该产品系列包括高速扫描器 FM510 和 FM530、功能全面的 FM550 以及智慧摄影机 FM600，所有这些产品都旨在推动 IVD检查室的自动化，提高诊断速度和准确性。此次新产品发布表明，诊断品管领域对自动化和资料完整性的关注度日益提高。

目录

第一章：执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球体外诊断（IVD）品管市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单：主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章：全球市场趋势与策略

  • 关键科技与未来趋势
    • 生物技术、基因组学和精准医疗
    • 数位化、云端运算、巨量资料、网路安全
    • 人工智慧（AI）和自主人工智慧
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施、互联生态系统
  • 主要趋势
    • 人们越来越重视诊断的准确性和可靠性。
    • 人们越来越关注品质合规性和标准化
    • 扩大外部品质评估方案的采用范围
    • 扩大多重和分子诊断测试的验证范围
    • 扩大自动化品质监控系统的应用

第五章 终端用户产业市场分析

  • 医院
  • 临床检查室
  • 诊断中心
  • 研究和学术机构
  • 标准检验组织

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及 COVID-19 疫情对市场的影响。

第七章：全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球体外诊断（IVD）品管市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球体外诊断（IVD）品管市场规模、对比及成长率分析
  • 全球体外诊断（IVD）品管市场表现：规模与成长，2020-2025年
  • 全球体外诊断（IVD）品管市场预测：规模与成长，2025-2030年，2035年预测

第八章：全球市场总规模（TAM）

第九章 市场细分

  • 依产品类型
  • 品管产品、资料管理解决方案、品质保证服务
  • 按製造商类型
  • 体外诊断设备製造商，第三方品管製造商
  • 透过使用
  • 临床化学、血液学、免疫检测、分子诊断、微生物学、凝血及止血及其他应用。
  • 最终用户
  • 医院、临床检查室、研究和学术机构以及其他最终用户
  • 按类型细分：品管产品
  • 标准材料、品管工具包和能力测试样品。
  • 按类型细分：资料管理解决方案
  • 品管软体、数据分析工具和基于云端的解决方案。
  • 按类型细分：品质保证服务
  • 咨询服务、培训和教育服务、审计和合规服务

第十章 区域与国别分析

  • 全球体外诊断（IVD）品管市场：按地区划分，实际数据和预测数据，2020-2025年、2025-2030年、2035年
  • 全球体外诊断（IVD）品管市场：按国家划分，实际结果和预测，2020-2025年、2025-2030年、2035年

第十一章 亚太市场

第十二章：中国市场

第十三章：印度市场

第十四章：日本市场

第十五章：澳洲市场

第十六章：印尼市场

第十七章：韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第20章 西欧市场

第21章英国市场

第22章：德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章：东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第三十章：加拿大市场

第31章：南美市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第三十五章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 体外诊断（IVD）品管市场：竞争格局与市场份额，2024年
  • 体外诊断（IVD）品管市场：公司评估矩阵
  • 体外诊断（IVD）品管市场：公司简介
    • Bio-Rad Laboratories Inc.
    • Thermo Fisher Scientific Inc.
    • LGC Limited.
    • Abbott Laboratories
    • Roche Diagnostics AG

第37章 其他大型企业和创新企业

  • Siemens AG, Ortho Clinical Diagnostics Inc., Helena Laboratories Corporation, Quidel Corporation, Microbiologics Inc., Sun Diagnostics LLC, Fortress Diagnostics Ltd., Seegene Inc., Bio-Techne Corp., Randox Laboratories, Danaher Corporation, Sysmex Corporation, Beckman Coulter Inc., Grifols India Healthcare Private Limited., Hologic Inc.

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：具有高市场潜力的国家、细分市场与策略

  • 2030年体外诊断（IVD）品管市场：提供新机会的国家
  • 2030年体外诊断（IVD）品管市场：充满新机会的细分市场
  • 2030年体外诊断（IVD）品管市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第41章附录

简介目录
Product Code: SE3MIVDI01_G26Q1

In-vitro diagnostics (IVD) quality control encompasses a set of processes designed to ensure the accuracy, performance, and environmental conditions impacting in vitro diagnostic tests, including in vitro nucleic acid testing processes for pathogen detection and healthcare-associated infections (HAIs) like pneumonia and urinary tract infections.

The primary products in in-vitro diagnostics quality control include quality control products, data management solutions, and quality assurance services. Quality control products comprise serum/plasma-based control products, whole blood-based control products, urine-based control products, and other control products manufactured by IVD instrument manufacturers. These products aim to cure, mitigate, or treat conditions through in-vitro diagnostics quality control. Manufacturers can be categorized as IVD instrument manufacturers and third-party quality control manufacturers. These products find applications in various diagnostic areas, such as clinical chemistry, hematology, immunoassay, molecular diagnostics, microbiology, coagulation, or hemostasis, among others. The implementation of in-vitro diagnostics quality control occurs in various settings, including hospitals, clinical laboratories, research and academic institutes, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the in vitro diagnostics quality control market by increasing the costs of control materials, software platforms, and quality assurance kits that depend on cross border manufacturing and sourcing. These effects are particularly evident in molecular diagnostics, immunoassay, and clinical chemistry segments, as well as in regions where IVD imports form a major share of supply such as Asia Pacific and Europe. However, tariffs are also encouraging localization of IVD quality control production and regional manufacturing investments, supporting domestic capability building. Overall, tariffs are reshaping procurement strategies while pushing stakeholders toward supply diversification and cost optimization initiatives.

The in vitro diagnostics (ivd) quality control market research report is one of a series of new reports from The Business Research Company that provides in vitro diagnostics (ivd) quality control market statistics, including in vitro diagnostics (ivd) quality control industry global market size, regional shares, competitors with a in vitro diagnostics (ivd) quality control market share, detailed in vitro diagnostics (ivd) quality control market segments, market trends and opportunities, and any further data you may need to thrive in the in vitro diagnostics (ivd) quality control industry. This in vitro diagnostics (ivd) quality control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in vitro diagnostics (ivd) quality control market size has grown strongly in recent years. It will grow from $1.48 billion in 2025 to $1.61 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to growing burden of infectious diseases, rising adoption of in vitro diagnostic devices, regulatory focus on diagnostic accuracy, expansion of clinical laboratory networks, increasing awareness of testing quality standards.

The in vitro diagnostics (ivd) quality control market size is expected to see strong growth in the next few years. It will grow to $2.24 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rising demand for molecular diagnostics precision, increasing healthcare digitalization, growing adoption of automated lab systems, expanding healthcare infrastructure investments, stricter regulatory compliance requirements. Major trends in the forecast period include increasing emphasis on diagnostic accuracy and reliability, rising focus on quality compliance and standardization, growing adoption of external quality assessment programs, expansion of multiplex and molecular diagnostic testing validation, increasing use of automated quality monitoring systems.

The rising prevalence of infectious diseases is expected to propel the growth of the in vitro diagnostics (IVD) quality control market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly between individuals. The prevalence of infectious diseases is increasing due to factors such as growing antimicrobial resistance, which makes common infections more difficult to treat and control, thereby facilitating wider transmission. IVD quality control plays a critical role in ensuring the accuracy, reliability, and consistency of diagnostic test results, enabling timely detection of infectious pathogens and supporting effective clinical decision-making and patient management. For instance, in October 2024, according to the World Health Organization (WHO), a Switzerland-based international public health organization, approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, an increase from about 7.5 million in 2022, making tuberculosis the leading infectious disease killer globally. Therefore, the rising prevalence of infectious diseases is driving the growth of the in vitro diagnostics (IVD) quality control market.

Major companies operating in the in vitro diagnostics (IVD) quality control market are focusing on integrating advanced technologies such as embedded barcode-scanning systems to improve efficiency, streamline diagnostic workflows, and reduce processing errors. Embedded barcode-scanning systems are compact fixed-mount devices and smart vision modules that automatically read barcodes and capture data in real time, enabling accurate specimen identification, automated data entry, and enhanced traceability throughout the diagnostic process. For instance, in November 2023, Newland EMEA, a Netherlands-based digital technology company, launched a new line of IVD-focused barcode-scanning products at the MEDICA trade fair. The portfolio includes high-speed scanners such as the FM510 and FM530, the versatile FM550, and the smart FM600 camera, all designed to enhance automation, improve diagnostic speed, and increase accuracy in IVD laboratories. This launch highlights the growing emphasis on automation and data integrity in diagnostic quality control.

In May 2024, Bruker, a US-based analytical instrumentation company, acquired ELITechGroup for €870 ($948) million. This acquisition aims to strengthen Bruker's position in the molecular diagnostics market by integrating ELITech's innovative sample-to-answer platforms along with its diverse portfolio of assays for infectious diseases. ELITech, also a US-based in-vitro diagnostics company, develops, manufactures, and markets a wide range of advanced diagnostic products and solutions, which include instruments, reagents, and software.

Major companies operating in the in vitro diagnostics (ivd) quality control market report are Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., LGC Limited., Abbott Laboratories, Roche Diagnostics AG, Siemens AG, Ortho Clinical Diagnostics Inc., Helena Laboratories Corporation, Quidel Corporation, Microbiologics Inc., Sun Diagnostics LLC, Fortress Diagnostics Ltd., Seegene Inc., Bio-Techne Corp., Randox Laboratories, Danaher Corporation, Sysmex Corporation, Beckman Coulter Inc., Grifols India Healthcare Private Limited., Hologic Inc., Qiagen NV, Becton Dickinson and Company, Luminex Corporation, BioMerieux SA, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ZeptoMetrix Corporation, Maine Molecular Quality Controls Inc.

North America was the largest region in the in vitro diagnostics (IVD) quality control market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostics (ivd) quality control market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in vitro diagnostics (ivd) quality control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The in-vitro diagnostics (IVD) quality control market consists of revenues earned by entities that evaluate and validate the reliability of in-vitro diagnostics testing systems. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vitro Diagnostics (IVD) Quality Control Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses in vitro diagnostics (ivd) quality control market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in vitro diagnostics (ivd) quality control ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in vitro diagnostics (ivd) quality control market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product type: Quality Control Products; Data Management Solutions; Quality Assurance Services
  • 2) By Manufacturer Type: IVD Instrument Manufacturers; Third Party Quality Control Manufacturers
  • 3) By Application: Clinical Chemistry; Hematology; Immunoassay; Molecular Diagnostics; Microbiology; Coagulation Or Hemostasis; Other Applications
  • 4) By End-Users: Hospitals; Clinical Laboratories; Research And Academic Institutes; Other End Users
  • Subsegments:
  • 1) By Quality Control Products: Control Materials; Quality Control Kits; Proficiency Testing Samples
  • 2) By Data Management Solutions: Software For Quality Control Management; Data Analysis Tools; Cloud-Based Solutions
  • 3) By Quality Assurance Services: Consulting Services; Training And Education Services; Audit And Compliance Services
  • Companies Mentioned: Bio-Rad Laboratories Inc.; Thermo Fisher Scientific Inc.; LGC Limited.; Abbott Laboratories; Roche Diagnostics AG; Siemens AG; Ortho Clinical Diagnostics Inc.; Helena Laboratories Corporation; Quidel Corporation; Microbiologics Inc.; Sun Diagnostics LLC; Fortress Diagnostics Ltd.; Seegene Inc.; Bio-Techne Corp.; Randox Laboratories; Danaher Corporation; Sysmex Corporation; Beckman Coulter Inc.; Grifols India Healthcare Private Limited.; Hologic Inc.; Qiagen NV; Becton Dickinson and Company; Luminex Corporation; BioMerieux SA; Meridian Bioscience Inc.; Sekisui Diagnostics LLC; ZeptoMetrix Corporation; Maine Molecular Quality Controls Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. In Vitro Diagnostics (IVD) Quality Control Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global In Vitro Diagnostics (IVD) Quality Control Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. In Vitro Diagnostics (IVD) Quality Control Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global In Vitro Diagnostics (IVD) Quality Control Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Emphasis On Diagnostic Accuracy And Reliability
    • 4.2.2 Rising Focus On Quality Compliance And Standardization
    • 4.2.3 Growing Adoption Of External Quality Assessment Programs
    • 4.2.4 Expansion Of Multiplex And Molecular Diagnostic Testing Validation
    • 4.2.5 Increasing Use Of Automated Quality Monitoring Systems

5. In Vitro Diagnostics (IVD) Quality Control Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinical Laboratories
  • 5.3 Diagnostic Centers
  • 5.4 Research And Academic Institutes
  • 5.5 Reference Laboratories

6. In Vitro Diagnostics (IVD) Quality Control Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global In Vitro Diagnostics (IVD) Quality Control Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global In Vitro Diagnostics (IVD) Quality Control PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global In Vitro Diagnostics (IVD) Quality Control Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global In Vitro Diagnostics (IVD) Quality Control Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global In Vitro Diagnostics (IVD) Quality Control Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global In Vitro Diagnostics (IVD) Quality Control Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. In Vitro Diagnostics (IVD) Quality Control Market Segmentation

  • 9.1. Global In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Quality Control Products, Data Management Solutions, Quality Assurance Services
  • 9.2. Global In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Manufacturer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • IVD Instrument Manufacturers, Third Party Quality Control Manufacturers
  • 9.3. Global In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinical Chemistry, Hematology, Immunoassay, Molecular Diagnostics, Microbiology, Coagulation Or Hemostasis, Other Applications
  • 9.4. Global In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinical Laboratories, Research And Academic Institutes, Other End Users
  • 9.5. Global In Vitro Diagnostics (IVD) Quality Control Market, Sub-Segmentation Of Quality Control Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Control Materials, Quality Control Kits, Proficiency Testing Samples
  • 9.6. Global In Vitro Diagnostics (IVD) Quality Control Market, Sub-Segmentation Of Data Management Solutions, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Software For Quality Control Management, Data Analysis Tools, Cloud-Based Solutions
  • 9.7. Global In Vitro Diagnostics (IVD) Quality Control Market, Sub-Segmentation Of Quality Assurance Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consulting Services, Training And Education Services, Audit And Compliance Services

10. In Vitro Diagnostics (IVD) Quality Control Market Regional And Country Analysis

  • 10.1. Global In Vitro Diagnostics (IVD) Quality Control Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global In Vitro Diagnostics (IVD) Quality Control Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market

  • 11.1. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China In Vitro Diagnostics (IVD) Quality Control Market

  • 12.1. China In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India In Vitro Diagnostics (IVD) Quality Control Market

  • 13.1. India In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan In Vitro Diagnostics (IVD) Quality Control Market

  • 14.1. Japan In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia In Vitro Diagnostics (IVD) Quality Control Market

  • 15.1. Australia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia In Vitro Diagnostics (IVD) Quality Control Market

  • 16.1. Indonesia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea In Vitro Diagnostics (IVD) Quality Control Market

  • 17.1. South Korea In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan In Vitro Diagnostics (IVD) Quality Control Market

  • 18.1. Taiwan In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia In Vitro Diagnostics (IVD) Quality Control Market

  • 19.1. South East Asia In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe In Vitro Diagnostics (IVD) Quality Control Market

  • 20.1. Western Europe In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK In Vitro Diagnostics (IVD) Quality Control Market

  • 21.1. UK In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany In Vitro Diagnostics (IVD) Quality Control Market

  • 22.1. Germany In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France In Vitro Diagnostics (IVD) Quality Control Market

  • 23.1. France In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy In Vitro Diagnostics (IVD) Quality Control Market

  • 24.1. Italy In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain In Vitro Diagnostics (IVD) Quality Control Market

  • 25.1. Spain In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe In Vitro Diagnostics (IVD) Quality Control Market

  • 26.1. Eastern Europe In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia In Vitro Diagnostics (IVD) Quality Control Market

  • 27.1. Russia In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America In Vitro Diagnostics (IVD) Quality Control Market

  • 28.1. North America In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA In Vitro Diagnostics (IVD) Quality Control Market

  • 29.1. USA In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada In Vitro Diagnostics (IVD) Quality Control Market

  • 30.1. Canada In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America In Vitro Diagnostics (IVD) Quality Control Market

  • 31.1. South America In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil In Vitro Diagnostics (IVD) Quality Control Market

  • 32.1. Brazil In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East In Vitro Diagnostics (IVD) Quality Control Market

  • 33.1. Middle East In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa In Vitro Diagnostics (IVD) Quality Control Market

  • 34.1. Africa In Vitro Diagnostics (IVD) Quality Control Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa In Vitro Diagnostics (IVD) Quality Control Market, Segmentation By Product type, Segmentation By Manufacturer Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. In Vitro Diagnostics (IVD) Quality Control Market Regulatory and Investment Landscape

36. In Vitro Diagnostics (IVD) Quality Control Market Competitive Landscape And Company Profiles

  • 36.1. In Vitro Diagnostics (IVD) Quality Control Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. In Vitro Diagnostics (IVD) Quality Control Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. In Vitro Diagnostics (IVD) Quality Control Market Company Profiles
    • 36.3.1. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. LGC Limited. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Roche Diagnostics AG Overview, Products and Services, Strategy and Financial Analysis

37. In Vitro Diagnostics (IVD) Quality Control Market Other Major And Innovative Companies

  • Siemens AG, Ortho Clinical Diagnostics Inc., Helena Laboratories Corporation, Quidel Corporation, Microbiologics Inc., Sun Diagnostics LLC, Fortress Diagnostics Ltd., Seegene Inc., Bio-Techne Corp., Randox Laboratories, Danaher Corporation, Sysmex Corporation, Beckman Coulter Inc., Grifols India Healthcare Private Limited., Hologic Inc.

38. Global In Vitro Diagnostics (IVD) Quality Control Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The In Vitro Diagnostics (IVD) Quality Control Market

40. In Vitro Diagnostics (IVD) Quality Control Market High Potential Countries, Segments and Strategies

  • 40.1 In Vitro Diagnostics (IVD) Quality Control Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 In Vitro Diagnostics (IVD) Quality Control Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 In Vitro Diagnostics (IVD) Quality Control Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer